West Pharmaceutical Services, Inc. (NYSE: WST)

This lawsuit is for anyone who acquired securities in West Pharmaceutical Services, Inc. (NYSE: WST) from February 16, 2023 through February 12, 2025.

The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, the lawsuit alleges that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company misled investors by telling investors that the Company was experiencing a temporary slowdown in sales related to customers selling through their excess COVID inventory when the Company knew that it was actually experiencing a lessening in demand across its high-margin High-Value Products.

On February 13, 2025, West issued disappointing revenue and earnings forecasts for 2025, attributing it, in part, to Contract Manufacturing headwinds, including the loss of two major continuous glucose monitoring customers. Additionally, West disclosed that its SmartDose wearable injector devices would be “margin dilutive” in 2025 and that it would be “taking steps to improve [its SmartDose] economics, and all options are on the table.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in West Pharmaceutical Services, Inc. (NYSE: WST) from February 16, 2023 through February 12, 2025 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.